Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design
Titel:
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design
Auteur:
Jain, Sneha S. Mahaffey, Kenneth W. Pieper, Karen S. Shimizu, Wataru Potpara, Tatjana Ruff, Christian T. Kamel, Hooman Lewis, Basil S. Cornel, Jan H. Kowey, Peter R. Horrow, Jay Strony, John Plotnikov, Alexei N. Li, Danshi Weng, Stephen Donahue, Julia Gibson, C. Michael Steg, P. Gabriel Mehran, Roxana Weitz, Jeffrey I. Johnston, S. Claiborne Hankey, Graeme J. Harrington, Robert A. Lam, Carolyn S.P.